Results 151 to 160 of about 10,287 (203)

Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease-A Narrative Clinical Review. [PDF]

Pharmaceuticals (Basel)
Velidakis N, Stachteas P, Gkougkoudi E, Papadopoulos C, Kadoglou NPE.   +4 more
europepmc   +1 more source

Structural, Spectroscopic, and Docking Analysis of N,O-Donor Ligand Metal Complex Nanoparticles With Hypolipidemic Effects via Lipoprotein Lipase Activation in High-Fat Diet Mice. [PDF]

Chem Biodivers
Abd El-Hamid SM, Aziz SW, Mohamed AA, El-Gedamy MS, Salem AE, Mohammed SF, Zordok WA, Sofo A, Sabry MA, Sadeek SA, Elshafie HS.   +10 more
europepmc   +1 more source

Inclisiran in Cardiovascular Health: A Review of Mechanisms, Efficacy, and Future Prospects. [PDF]

Med Sci Monit
Huang F, Dai Q, Zhou Y, Guan J, Wu J, Dong Y, Lv J.   +6 more
europepmc   +1 more source

Causal Association Between Lipid-Lowering Drugs and Glaucoma: A Drug-Targeted Mendelian Randomization Study. [PDF]

Invest Ophthalmol Vis Sci
Liu Y, Li T.
europepmc   +1 more source

AMPK-Mediated Hypolipidemic Effects of a Salvia miltiorrhiza and Paeonia lactiflora Mixed Extract on High-Fat Diet-Induced Liver Triglyceride Accumulation: An In Vivo and In Vitro Study. [PDF]

Nutrients
Son J, Phong NV, Cha MR, Oh B, Song S, Yang SY.   +5 more
europepmc   +1 more source

Investigating potent cardioprotective compounds as ACE inhibitors in Saraca asoca. [PDF]

Toxicol Rep
Prasad S, Younis K, Yousuf O.
europepmc   +1 more source

Anti-atherosclerotic effects of natural compounds targeting lipid metabolism and inflammation: Focus on PPARs, LXRs, and PCSK9. [PDF]

Atheroscler Plus
Palumbo M, Ugolotti M, Zimetti F, Adorni MP.   +3 more
europepmc   +1 more source

Liver-targeting iron oxide nanoparticles and their complexes with plant extracts for biocompatibility. [PDF]

Beilstein J Nanotechnol
Kazaryan SA, Oganian SA, Vardanyan GS, Sidorenko AS, Hovhannisyan AA.   +4 more
europepmc   +1 more source

Lipid Biomarkers and Cardiometabolic Diseases: Critical Knowledge Gaps and Future Research Directions. [PDF]

Metabolites
Yang HS.
europepmc   +1 more source

<i>Rosmarinus officinalis</i> L. as Fascinating Source of Potential Anticancer Agents Targeting Aromatase and COX-2: An Overview. [PDF]

Molecules
Gargano A, Greco I, Lupia C, Alcaro S, Ambrosio FA.   +4 more
europepmc   +1 more source